PDE5A and Stroke: Similar results have been seen with another phosphodiesterase inhibitor dipyridamole (PDE5 inhibitor) with mild-antiplatelet and proendothelial effects,2 which reduced stroke recurrence while increasing headache, mostly in Western populations.